Blood markers in mycosis fungoides and Sézary syndrome

British Journal of DermatologyVolume 185, Issue 2 p. e38-e38 Plain Language SummaryFree Access Blood markers in mycosis fungoides and Sézary syndrome First published: 16 August 2021 https://doi.org/10.1111/bjd.20530AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text full-text accessPlease review our Terms Conditions Use check box below share version article.I have read accept the Wiley Online Library UseShareable LinkUse link a this article with your friends colleagues. Learn more.Copy URL Share linkShare onFacebookTwitterLinked InRedditWechat Abstract Linked Article: Dobos et al. Br J Dermatol 2021; 185:405–411. This study from Paris, France, looked at five substances (markers) blood see if they might help diagnosis (MF) (SS), types lymphoma (an immune system cancer) that affect skin. It can be difficult separate these conditions benign (non-cancerous) skin each other. Early MF, for example, may resemble eczema or psoriasis, whereas severe MF make red inflamed all over (a state known as erythroderma) – but erythroderma also occurs SS, psoriasis. Special tests are therefore routinely performed on samples try distinguish SS. In where there abnormal lymphocytes bloodstream, special samples. There is room improvement methods, hence research looking four previously reported possibly helpful SS advanced erythrodermic fifth useful early MF. The results 447 patients other lymphomas diseases, varying severity, showed three T-plastin, Twist KIR3DL2 might, combination, conditions, although not conditions. was hint predict relapse. remaining NKp46 Tox were less and, contrary previous reports, Volume185, Issue2August 2021Pages RelatedInformation